Cowen Cuts Price Target on RPX Corporation (RPXC) Following 3Q Results

Cowen reiterated an Outperform rating on RPX Corp (NASDAQ: RPXC), and cut the price target to $17.00 (from $18.00), following the company's 3Q earnings results. Revenue and non-GAAP EPS of $68.2MM and $0.19 were in-line with the Street $70.2MM and $0.19 estimates. The company continues to make strong progress on winning and retaining new, emerging growth clients and should soon begin to fully capitalize on its growing broker channel to drive top-line growth.

Analyst Timothy Arcuri commented, "While CQ4 was implicitly cut, core subscription revenue remains unchanged, as does the story. The build-out of insurance is the next step on a road to findings ways to monetize its market intelligence. Target to $17."

For an analyst ratings summary and ratings history on RPX Corp click here. For more ratings news on RPX Corp click here.

Shares of RPX Corp closed at $15.13 yesterday.

You May Also Be Interested In

• Natera (NTRA) PT Raised to $270 at BTIG
• Globe Life (GL) PT Raised to $215 at TD Cowen
• Cytokinetics (CYTK) PT Raised to $118 at Mizuho